MKI67 and neoplasm: Moreover, in patients with pancreatic and intestinal NETs, FAPI PET/CT has been demonstrated to be a potentially valuable predictor of lesion aggressiveness and risk of progression, considering the very good correlation between FAPI PET/CT-derived tumor fractions and Ki-67, which is much better than the [18F]FDG-derived one [24].